Environmental eHealth : A critical compenent of eHealth readiness assessment by Richard Scott, CEO & Principal
Consultant for NT Consulting, Editor - Journal ISfTeH, Canada
Availability and Utilization of Health Informatics System among Health Worker...ijtsrd
With a clear flow of information across many medical subsystems, the adoption and utility of electronic health record systems EHRs improve the healthcare system going forward. The study is about the availability and utilization of health informatics systems among health Workers in Niger State, Nigeria. In this study, the channel model was used to describe how the information is flow in the health sectors. The study adopts quantitative approaches to investigate the availability and utility of health informatics among health workers in Niger state, Nigeria. The population of the study comprised all the health workers working in public health hospitals and clinics in Niger State totalling about 3,599 health workers out of which 400 were sampled using appropriate sample size determination. The returned rate of 320 instruments was used for the analysis. The study revealed that the health informatics system was not available and as such the utilisation was relatively very low in Niger state. The study recommends among others that there is a need for the Nigerian government and health managers to make use of health informatics to improve the delivery of the healthcare system. Eucharia Hauwa, Umoru | Dr. A. H. Ibrahim | Dr. Abdulrahman M. Sani "Availability and Utilization of Health Informatics System among Health Workers in Niger State, Nigeria" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-6 | Issue-7 , December 2022, URL: https://www.ijtsrd.com/papers/ijtsrd52351.pdf Paper URL: https://www.ijtsrd.com/medicine/nursing/52351/availability-and-utilization-of-health-informatics-system-among-health-workers-in-niger-state-nigeria/eucharia-hauwa-umoru
Sterilization Validation for Medical DevicesDocKetchum
Every medical device produced must be sterilized before being shipped to hospitals, doctors’ offices, and other medical locations.
Random samples of these devices must then be tested to be sure the sterilization kills disease causing microbes including bacteria, fungus, and spores in every device.
These are some of the most common ways that sterilization validation is performed.
Single use technology: a regulatory perspectiveTGA Australia
An overview of the regulation of single use technology including Good Manufacturing Practice requirements and the types of deficiencies and issues observed at inspections
Availability and Utilization of Health Informatics System among Health Worker...ijtsrd
With a clear flow of information across many medical subsystems, the adoption and utility of electronic health record systems EHRs improve the healthcare system going forward. The study is about the availability and utilization of health informatics systems among health Workers in Niger State, Nigeria. In this study, the channel model was used to describe how the information is flow in the health sectors. The study adopts quantitative approaches to investigate the availability and utility of health informatics among health workers in Niger state, Nigeria. The population of the study comprised all the health workers working in public health hospitals and clinics in Niger State totalling about 3,599 health workers out of which 400 were sampled using appropriate sample size determination. The returned rate of 320 instruments was used for the analysis. The study revealed that the health informatics system was not available and as such the utilisation was relatively very low in Niger state. The study recommends among others that there is a need for the Nigerian government and health managers to make use of health informatics to improve the delivery of the healthcare system. Eucharia Hauwa, Umoru | Dr. A. H. Ibrahim | Dr. Abdulrahman M. Sani "Availability and Utilization of Health Informatics System among Health Workers in Niger State, Nigeria" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-6 | Issue-7 , December 2022, URL: https://www.ijtsrd.com/papers/ijtsrd52351.pdf Paper URL: https://www.ijtsrd.com/medicine/nursing/52351/availability-and-utilization-of-health-informatics-system-among-health-workers-in-niger-state-nigeria/eucharia-hauwa-umoru
Sterilization Validation for Medical DevicesDocKetchum
Every medical device produced must be sterilized before being shipped to hospitals, doctors’ offices, and other medical locations.
Random samples of these devices must then be tested to be sure the sterilization kills disease causing microbes including bacteria, fungus, and spores in every device.
These are some of the most common ways that sterilization validation is performed.
Single use technology: a regulatory perspectiveTGA Australia
An overview of the regulation of single use technology including Good Manufacturing Practice requirements and the types of deficiencies and issues observed at inspections
Antibiotics are most common therapeutic agents used in hospitals across world, however, microbial world is becoming resistant day by day, posing special challenges to clinicians specially working in ICU set ups. There are multiple ways to curb this menace, if approached together in antibiotic stewardship way, can bring about wonders and retain therapeutic potentials of these drugs.
This presentation gives an overview of : Validation of microbiological methods , Considering some of the limitations and
Key criteria that may be applicable for assessment.
Pharmaceutical Microbiology: Current and Future Challenges Tim Sandle, Ph.D.
The changing environment for pharmaceutical microbiology
Limitations of methods
Need for new (rapid) methods
Separating people form processes
Single-use technologies
Environmental monitoring programme
Best practices
Rapid methods
Contamination control strategy
Objectionable organisms
Burkholderia cepacia complex
Clinical study types and designs are terms which represent the way in which clinical trials are structured and formulated.
Since we all know that clinical research is an extremely complex topic and not everything can be explained in a simple way, here we’ll focus only on some of the most basic types of clinical study types and designs which involve human subjects or participants.
First of all, you should know that the most basic grouping of study designs is experimental (treatment) studies and observational studies.
As we can suppose from the names, in an observational study, researchers have less control over subjects and they’re just observing what happens to subjects, while in experimental studies, researchers are using different methods (such as randomization) to place subjects in separate groups. This gives experimental studies much more validity than observational studies.
In this guide, we’ll talk about the 2 possible types of studies, as well as different study designs within.
ANTIBIOTIC RESISTANCE
BY- RICHA KRISHNA
(M.PHARMACY)
Antibiotic resistance occurs when bacteria change in response to the use of these medicines. Bacteria, not humans or animals, become antibiotic-resistant. These bacteria may infect humans and animals, and the infections they cause are harder to treat than those caused by non-resistant bacteria.
Watch the presentation of this webinar here: https://bit.ly/3tDy8Ei
Recent PDA/BioPhorum publications outline risks for PUPSIT in sterilizing filtration. This webinar will summarize the key points and best practices for implementing PUPSIT.
PDA and BioPhorum have partnered to form a task force whose goal was to provide the industry and regulators with scientific data and analysis on the potential risks and benefits of implementing PUPSIT to improve sterility assurance. This webinar will describe the data generated by the task force studies and discuss considerations and best practices when implementing PUPSIT.
In this webinar, you will learn:
• How changing industry perspectives help overcome regulatory concerns and may influence regulatory perspective
• How improved process understanding affects risk assessment
• How improved final fill assembly design simplifies PUPSIT
Here i have made an introduction to the notification system in Sri Lanka. it is a component of national disease surveillance system. information here very important to final year MBBS and ERPM students.
Introduction to Descriptive Epidemiology.pptxAB Rajar
Descriptive Epidemiology is a branch of observation epidemiology, which particularly study about disease frequency and pattern by time, place, and person.
It deals with the distribution and determinants of the factors related to health or disease in the concerned population.
It measures the magnitudes of the disease or other health-related disorder in the form of incidence and prevalence
Antibiotics are most common therapeutic agents used in hospitals across world, however, microbial world is becoming resistant day by day, posing special challenges to clinicians specially working in ICU set ups. There are multiple ways to curb this menace, if approached together in antibiotic stewardship way, can bring about wonders and retain therapeutic potentials of these drugs.
This presentation gives an overview of : Validation of microbiological methods , Considering some of the limitations and
Key criteria that may be applicable for assessment.
Pharmaceutical Microbiology: Current and Future Challenges Tim Sandle, Ph.D.
The changing environment for pharmaceutical microbiology
Limitations of methods
Need for new (rapid) methods
Separating people form processes
Single-use technologies
Environmental monitoring programme
Best practices
Rapid methods
Contamination control strategy
Objectionable organisms
Burkholderia cepacia complex
Clinical study types and designs are terms which represent the way in which clinical trials are structured and formulated.
Since we all know that clinical research is an extremely complex topic and not everything can be explained in a simple way, here we’ll focus only on some of the most basic types of clinical study types and designs which involve human subjects or participants.
First of all, you should know that the most basic grouping of study designs is experimental (treatment) studies and observational studies.
As we can suppose from the names, in an observational study, researchers have less control over subjects and they’re just observing what happens to subjects, while in experimental studies, researchers are using different methods (such as randomization) to place subjects in separate groups. This gives experimental studies much more validity than observational studies.
In this guide, we’ll talk about the 2 possible types of studies, as well as different study designs within.
ANTIBIOTIC RESISTANCE
BY- RICHA KRISHNA
(M.PHARMACY)
Antibiotic resistance occurs when bacteria change in response to the use of these medicines. Bacteria, not humans or animals, become antibiotic-resistant. These bacteria may infect humans and animals, and the infections they cause are harder to treat than those caused by non-resistant bacteria.
Watch the presentation of this webinar here: https://bit.ly/3tDy8Ei
Recent PDA/BioPhorum publications outline risks for PUPSIT in sterilizing filtration. This webinar will summarize the key points and best practices for implementing PUPSIT.
PDA and BioPhorum have partnered to form a task force whose goal was to provide the industry and regulators with scientific data and analysis on the potential risks and benefits of implementing PUPSIT to improve sterility assurance. This webinar will describe the data generated by the task force studies and discuss considerations and best practices when implementing PUPSIT.
In this webinar, you will learn:
• How changing industry perspectives help overcome regulatory concerns and may influence regulatory perspective
• How improved process understanding affects risk assessment
• How improved final fill assembly design simplifies PUPSIT
Here i have made an introduction to the notification system in Sri Lanka. it is a component of national disease surveillance system. information here very important to final year MBBS and ERPM students.
Introduction to Descriptive Epidemiology.pptxAB Rajar
Descriptive Epidemiology is a branch of observation epidemiology, which particularly study about disease frequency and pattern by time, place, and person.
It deals with the distribution and determinants of the factors related to health or disease in the concerned population.
It measures the magnitudes of the disease or other health-related disorder in the form of incidence and prevalence
Telemedicine in Otolaryngology Past, Present & Future by Piotr Henryk Skarzyñski, Director of Science & Development, Institute of Sensory Organs, Medical University of Warsaw, Poland
Current regulations regarding eHealth in Europe by Frank Lievens, Executive Secretariat ISfTeH Director, Managing Director Lievens-Lanckman bvba, Belgium
Creating large scale telehealth network : A story from the USA by Adam Darkins, Vice President, Medical Affairs & Enterprise Technology Development, Medtronics, USA
WhatsApp Telemedicine For the Developing World: What Can We Learn From India by Maurice Mars Head Dept of TeleHealth, Nelson, R Mandela School of Medicine @ University of KwaZulu-Natal, South Africa
ICF Environmental Factors: catalyst for person-centred healthcareJanice Miller
This powerpoint presentation outlines the development process and features of Environmental Factors in the World Health Organization 2001 ICF. This presentation was delivered as part of the 2017 ICF Symposium in Cape Town, South Africa 2017
Healthcare delivery systems in India need a thorough look by reformist in India. Ehealth may be a probable option tool to help integrating hospital and community care
A presentation by Dr. Michelle A. Meade for the Investing in Abilities 2017 lecture series, on emerging technologies and tech strategies for empowerment.
A Proposed Framework for Supporting Behaviour Change by Translating Personali...Ulster University
The aim of this position paper is to examine the case for supporting behaviour change in pre-diabetic obese people in order to improve their health. The paper sets out the background and motivation for supporting behaviour change before outlining the relevant literature in this health and wellbeing area. The paper then explores the feasibility of SmartLife - a patient-driven application involving healthcare practitioners and peer support interaction with a focus on failure-free, positive reinforcement, patient empowerment and wellbeing.
Mobile health is an ever expanding field, and shows great promise for delivering care to remote patients. In this presentation at the ATA 2012 conference, Dr. Robert Ciulla demonstrates the potential for mHealth to improve care availability and how T2 is supporting that goal.
Implementation of Online Safety Incident Reporting System in a Tertiary Care Teaching Hospital by Dr. Bijoy Johnson, Dept. of Hospital Administration, KMC Manipal, India
Large Scale Disaster Management in Healthcare Deploying ICT by Olav Veum Eielsen Anesthesiologist, Director Regional Centre for Medical Emergency Research and Development,
Norway
Virtual knowledge network NIMHANS Echo : Innovative tele- mentoring model for skilled capacity building in addiction & mental health by Prabhat Chand , NIMHANS, India
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Environmental eHealth : A critical compenent of eHealth readiness assessment by Richard Scott
1. 1
ENVIRONMENTAL e-HEALTH
- A CRITICAL COMPONENT of e-HEALTH
READINESS ASSESSMENT -
Dr. Richard E. Scott 1,2 and Dr. Maurice Mars 2
1 NT Consulting – Global e-Health Inc., Calgary, Alberta, Canada; Departments of
Family Medicine and Community Health Sciences, University of Calgary, Calgary,
Alberta, Canada
2 Telehealth Department, University of KwaZulu-Natal, Durban, South Africa
3. e-Health
- Perspective -
Definition
• “The use of Information and
Communication Technologies
(ICT) for health”
• http://www.who.int/topics/ehealth/en/
Reality
• “There is no aspect of health
or healthcare that has not
been, is not being, or will not
be impacted by e-Health”
5. Environmental e-Health
- Perspective -
Environmental e-Health is:
•“The study of the impact of
e-health on the
environment (harms and
benefits) and means of
mitigation (harms) or
enhancement (benefits) of
these impacts.” Mt. Kilimanjaro has been the
subject of many scientific
studies because of its shrinking
glaciers
7. Environmental e-Health
- Environmental e-Health Impact Model -
e
W
A
S
T
E
Upstream Issues
Materials, Manufacturing,
Packaging, Distribution
Mid Strm
Use
(Energy / Water)
Downstream Issues
e-Waste / WEEE
(Recycling / Reuse)
R
E
S
O
U
R
C
E
D
E
P
L
E
T
I
O
N
ENERGY / GHGs
Holistic ‘Cradle to Grave’ or Life Cycle Analysis (LCA)
Understand the types of environmental impact of e-Health
Water Air Ground
Natural (Global) Environment
Opportunities for Change in Practice, Process, and Policy
9. e-Health Readiness
- Technology is not Enough !! -
“The degree to which users, health-
care institutions, and the health-care
system itself, are prepared to
participate and succeed with e-health
implementation.” Jennett et al. (2005)
10. Environmental e-Health Readiness
- Technology is not Enough !! -
“The degree to which users,
health-care institutions, and the
health-care system itself, are
aware of, and able to ameliorate,
environmental impact of e-health
implementations.” Scott and Mars. (2016)
11. Environmental e-Health Readiness
- Literature Search -
Papers Identified in e-
Databases
(PubMed + Google
Scholar) - 269
Papers After Duplicates
removed and Preliminary
Screen - 28
Papers Excluded: Non-
English; duplicates; ‘disaster’
related; no model or
framework - 241
e-Health Readiness
Models / Frameworks.
(e-Health OR eHealth OR Telemedicine OR Telehealth) AND (Readiness OR Preparedness)
12. •Models or frameworks noting the
environmental impact of e-health.
NONE
•Papers using the term ‘environment’
FOUR
•BUT - only in reference to the e-health
‘setting’
Environmental e-Health Readiness
- Findings -
14. Significance ?
- What WE Contribute -
• Twitter – a tweet ‘emits’
about 0.02g CO2
(50m/day = 1 tonne of
CO2
• Google – a search
query ‘emits’ 0.2g CO2
(= 3L water)
• e-Mail – each email
‘emits’ 0.25g CO2
15. Significance ?
- The Ever Increasing Volume of Activity -
Medium Per
SECOND
Per DAY Per YEAR
Tweets [1st] 10,520 15,148,800 5,529,312,000
Instagram Photos 2,963 4,266,720 1,557,352,800
Tumblr Posts 2,356 3,392,640 1,238,313,600
Skype calls 1,927 2,774,880 1,012,831,200
Google searches [2nd] 51,449 74,086,560 27,041,594,400
YouTube videos 111,132 160,030,080 58,410,979,200
e-Mails (mostly
spam!)
2,441,657 3,515,986,080 1,283,334,919,200
Internet traffic [3rd –
users]
30,949 GB 44,566,560 GB 16,266,794,400 GB
16. Sustainable e-Health
- Not Just Now – But the FUTURE !! -
A sustainable e-Health solution is:
”One that uses ICT resources to meet the
health needs of the present without
compromising the ability of future
generations to meet their own health
needs”.
Scott RE, 2009.
After: Bruntland Commission
18. • Be aware of:
• The existence of ‘Environmental e-Health’ as an issue
• The growing depth and breadth of global application
• Developed vs developing country realities
• Identify only:
• ‘Technologically appropriate’, ’culturally sensitive’, ‘locally
relevant’, and ‘environmentally sustainable’ e-health
solutions of overall value as determined by LCA
• Require:
• Meaningful EeIA from conception to termination (LCA)
• Influence / change:
• Policy, Process, and Practice to encompass EeH
Environmental e-Health
- Summary Thoughts ~ As Proponents WE must ….. -
Endorse – Enable - Enforce
19. Environmental e-Health Readiness
- Conclusion -
A setting (Country, Community, Institution, Individual) must:
• Recognise the environmental impact of e-health
• Have - in place - training, process, policy, enforcement
• Perform Environmental e-Health Impact Assessments
(EeIA) including LCA
• Ensure reduction of negative upstream, midstream, and
downstream environmental impacts
ONLY THEN is the setting truly ‘READY’ for implementation
of e-Health
20. Comments – Questions !?
- Environmental e-Health and Readiness Assessment -
Richard Scott: NTC.eHealthConsulting@gmail.com
Maurice Mars: mars@ukzn.ac.za